Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

vascular endothelial growth factor receptor tyrosine kinase inhibitor

(VAS-kyoo-ler EN-doh-THEE-lee-ul grothe FAK-ter reh-SEP-ter TY-ruh-seen KY-nays in-HIH-bih-ter)

A substance that blocks an enzyme needed to form blood vessels. Also called VEGFR tyrosine kinase inhibitor.

vascular endothelial growth factor receptor tyrosine kinase inhibitor

Search NCI's Dictionary of Cancer Terms